A recent article in Huff Post Business highlighted Mettrum Health Corp. (TSXV:MT.V), a vertically integrated provider of cannabis products located in Bowmanville, Ontario.
As quoted in the article:

Mettrum’s licensed production facilities span over 80,000 square feet of capacity, located on a total of over 80 acres of land. The Bowmanville location (one of two) is massive, and houses their client service team and part of the grow operations. We passed through a number of security checkpoints — something they take very seriously (maybe even more so than the Canadian government requires).
mettrum1
A good fact to note: I was informed that the entire process takes about three months from clone to harvest. It was fascinating to see the complexity of the operation — almost otherworldly — where each plant has a dedicated lamp and computer-automated filtration system in their grow pod for consistency and potency of supplemental nutrients.
Afterwards, we toured Mettrum’s extraction lab where their concentrated oils are produced. Mettrum’s cannabis oils were designed to address the demand from patients and health care professionals alike for alternative consumption methods of medical cannabis to exist. Since launching their oils in January of this year, Mettrum has witnessed firsthand the tremendous appetite for extracted products.
Touring these facilities made it obvious that medical-grade cannabis is way more than just a “medical marijuana” sign on a storefront. It would be very difficult to replicate what goes on inside these facilities without having the experience, real estate and capital to uphold such an impressive growing practice. I don’t care what anyone says, the proof is in the cannabis-infused pudding; patients who are looking to obtain safe medicine should highly consider doing so from a top-tier government regulated source that shows accountability to their product.


 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less